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ABSTRACT 
Telomere Elongation Through 
The Expression of UP1, 
A Derivative of hnRNP Al. (April 2002) 
Natalie Jean Tanner 
Department of Biomedical Science 
Texas A&M University 
Fellows Advisor: Dr. Jorge Piedrahita 
Department of Veterinary Anatomy and Public Health 
As little as a decade ago, the cloning of an eukaryotic organism was generally 
thought of as an element in a science fiction novel, however, today the procedure is a 
reality. Genetic modification of cloned animals is also becoming a feasible idea, one 
that has the potential to create cxtcnsive benefits in the areas of medicine and 
agriculture. Transgenic animals would make it possible to develop livestock that 
produce high amounts of lean meat or high volumes of milk without the use of 
hormones. Transgenic pigs have the potential to save hundreds of thousands of peoples' 
lives by providing organs for xenotransplantation; the transplant of an organ across 
species. There are many barriers leading to the production of transgenic animals, one 
being that the genetic modifications must be done in vitro. Often, before the necessary 
modifications are complete, the cultured somatic cells will have reached senescence, a 
genetically determined event defined as cell aging and eventually death. 
The specific cause of senescence has not been determined, but several 
contributing factors have been identified. The telomere, located at the end of the 
chromosome, has been proven to play a role in senescence, although it is not clear as to 
whether its structure or length is the larger determinant. It has been concluded that each 
time the cell divides, the telomere length shortens, eventually leading to the instability of 
the chromosome and senescence of the cell. Because telomere length continually 
decreases, somatic cells can undergo only a limited number of divisions before reaching 
senescence. My research is examining telomere lengthening in order to extend the 
cellular life span through the expression of a dominant-negative domain of the naturally 
occurring heterogeneous nuclear ribonucleoprotein A 1 (hnRNP-A I), a gene that has 
been linked to the telomere mechanism. A dominant-negative is a protein that has been 
modified to express some characteristics of that protein while repressing others. In this 
case, the dominant-negative domain UP I has the unique property of encasing the 
telomere while its mRNA splicing characteristics have been turned off. Theoretically 
this protective coat will encase the telomere and protect it from degradation during cell 
division, therefore delaying senescence of the cell. 
Once the dominant-negative UP I gene was isolated and introduced into porcine 
fetal fibroblast cells, colonies producing high UP I expression were selected and 
expanded. These colonies were then subject to several tests in order to determine the 
effects of the modified protein. The technique of Population Doubling Factor (PDF) was 
used to determine if the somatic cells have increased in their number of divisions 
compared to a control set of cells. Upon completion of PDF analysis, tests for 
telomerase activity, an enzyme proven to lengthen telomere length in stem cells, were 
conducted to rule out this confounding variable. 
Our results from the PDF trials did indicate cellular life extension in the somatic 
cells expressing UP1. Further tests examining telomere length and cellular karyotype 
must be explored before any definitive conclusions can be drawn, however, the PDF 
experiment yielded encouraging results as to the prospect of somatic cellular life 
extension in vitro. 
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INTRODUCTION 
Over the past one hundred years, the leading cause of death around the world has 
shifted from infectious diseases to chronic diseases. This shift is referred to as the 
epidemiological transition. Modern medicine has alleviated the major threats imposed by 
viruses and bacteria, only to find a dead end with cancers, neurological disorders such as 
Alzheimer's disease, and other types of chronic ailments. The causes and cures of these 
diseases have been under intensive study over the past twenty years, and recently the 
medical world has teamed up with the areas of molecular biology and genetics in attempt 
to approach these disorders from a different angle. 
Genetic modification and therapeutic cloning are being explored aggressively in 
hopes of finding new treatments for chronic diseases. These procedures are examples of 
research that is based in the field of biotechnology. Biotechnology has in a short time 
made numerous significant advances not only in medicine, but also in agriculture and 
environment. New cloning techniques have recently been developed in different species 
of animals, porcine being most pertinent to telomere elongation research. Cloning allows 
for the manipulation of specific genes and provides a means by which to make animal 
models of human diseases. These genetic manipulations also make it possible to produce 
elite animals that generate higher weights, leaner meat, and increased milk production 
without the use of supplemental hormones. Because of the versatility of the possible 
applications, genetic modification and cloning have the potential to benefit people around 
the world, 
This thesis follows the style and format of BIOLOGY OF REPRODUCTION. 
Extensive research has been conducted over the past twenty years in order to 
discover methods to genetically modify organisms. Natural mechanisms such as 
homologous recombination have been exploited in the past to achieve precise genetic 
modifications. To develop this technology, mouse embryonic stem cells (ES), which are 
highly efficient in homologous recombination, have a long cell life due to telomerase 
activity, and are efficient in nuclear transfer, were used. These properties make gene 
targeting in mouse ES cells somewhat straightforward. However, this has not proven to 
be the case in other species or in other cell types. Researchers began to investigate the 
use of somatic cell lines for nuclear transfer and cloning. 
Unfortunately, there are two primary problems with using somatic cells in 
cloning. First, their cell divisions are limited, ending in senescence in a shorter time as 
compared to stem cells. Genetic modifications require about 100 population doublings 
on average, and the modification of a single allele takes about thirty population 
doublings. Therefore, the simple modification of two alleles would be over the typical 
cellular senescence plateau, which is reached anywhere from thirty to fifty population 
doublings, dependent upon the cells used. Secondly, somatic cells have a very low rate 
of homologous recombination resulting in a highly inefficient genetic modification 
system. In order to effectively use these cells for cloning and gene targeting, both of 
these problems must be alleviated. 
A contributing factor to these obstacles is the fact that the mechanism of 
senescence is not completely understood. Several factors have been acknowledged as 
affecting cell death, one of the most major being the telomere. Scientists have found that 
the telomere does in fact affect the lent' of cell life, but it remains uncertain as to the 
mechanism of the process. The telomere is a terminal end of a chromosome that 
decreases in length with each cell division. Once telomeres become too short, the 
chromosome becomes unstable and the cell dies. Because telomere length of somatic 
cells continuously decreases, these cells are able to undergo only a limited number of 
divisions before reaching senescence. 
There are three factors that have been linked to the rate that a cell reaches 
senescence, including the presence of free radicals, the initial length of the telomere, and 
the rate at which the telomere is degraded. Research has been conducted in the area of 
telomere length, but it has mainly concentrated on the effects of the protein human 
telomerase reverse transcriptase (hTERT). 
This study examines telomere lengthening and extension of cellular life span 
through the expression of a shortened derivative of heterogeneous nuclear 
ribonucleoprotein Al (hnRNPA1), a gene that has been linked to the telomere 
maintenance mechanism. UP1, the dominant-negative derivative of hnRNPA1, directly 
binds to the telomere and in theory protects it from shortening during cell division. In 
mice, it has been shown that the lack of expression of hnRNPA1 results in abnormal 
telomere shortening (La Branche et al. , 1998). However, the replacement of the Al 
expression in those Al-deficient cells increased the telomere length. HnRNPA1's mutant 
gene UP1 had the same effect on telomere lengthening, but failed to retain its RNA 
splicing ability (Dallaire et a1. , 2000). In this research UP 1 was introduced into porcine 
fetal fibroblasts followed by a subsequent analysis of the cells and the effects of their 
dominant-negative expression. 
LITERATURE REVIEW 
Cell division is required for the survival of multicellular organisms that contain 
renewable tissues. With the exception of stem cells, somatic cells have a limited 
capacity to proliferate either in vivo or in vitro. Therefore, in order for precise genetic 
modifications of somatic cells to be achieved, replicative senescence must be overcome 
through the extension of cellular life. Several different elements play active roles in the 
cell life cycle and cellular senescence and these constituents must be understood in order 
to develop a logical supposition as to the contributing factors and effects of cellular 
senescence. 
The Telomere 
In 1938 Hermann J. Muller gathered the first evidence for telomeres from his 
light microscopic studies in Drosophila, AAer further investigation, it was discovered 
that the end region of a linear chromosome has a unique structure that causes it to 
behave in a way that is distinct from a free end or a double-stranded break. Prior to the 
establishment of any evidence in confirmation of his thoughts, Muller stated ". . . The 
terminal gene must have a special function, that of sealing the end of the chromosome, 
so to speak, and that for some reason a chromosome cannot persist indefinitely without 
having its ends thus 'sealed. '" Following Muller's initial discovery, much attention has 
been devoted to the research of the telomere and its affect on cell cycles and senescence. 
Telomeres are nucleoprotein structures on the ends of linear chromosomes 
distinguished in vertebrates by their hexanucleotide sequence (TTAGGG)„. Telomeric 
DNA consists of several kilobase-pairs of tandemly repeated sequences with a single- 
stranded overhang of the glycine-rich strand that makes up the terminal 3'-end of the 
chromosome. Numerous studies have shown that although the length of telomeric DNA 
varies between species, specific orientation is conserved in most telomeres and is, 
therefore, likely of functional importance (Henderson, 1987). 
The word telomere literally means end-part; coming from the two Greek roots 
telos (end) and meros (part). These segmented end structures play an important role in 
chromosome stability, nuclear structure, and certain chromosome movements during 
mitosis. Telomere ends are different from broken ends: the telomere's specialized 
structure causes the natural ends of linear chromosomes to behave differently from 
simple double-stranded breaks. This is of major importance because the detection of a 
double-stranded break immediately activates cell cycle checkpoints and the arrest of cell 
division (Fig. 1). This defense mechanism would be detrimental if activated by the 
telomere end, given that maintaining the integrity of the telomeric repeats is essential for 
cell survival (Bodnar et al. , 1998). 
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FIG. 1. Cell Cycle Checkpoints (Freshney, 2000) 
A double-stranded break may result in dicentric chromosomes, translocations, or 
deletions. In maize breaks resulting from the action of dicentric chromosomes, cause 
repeated rounds of breakage-fusion-bridge cycles, which lead to gross changes in cell 
karyotype (McClintock, 1941, 1942). Natural chromosome ends are not reactive in this 
way, although both the telomere and the double-stranded break are ends of linear DNA 
molecules. Telomeric chromosome ends do not cause delays in cell cycle progression, 
nor are they subject to DNA repair as are broken chromosome ends (Kurenova and 
Mason; 1997). These facts indicate that the telomere plays a role in maintaining 
chromosome stability and there is at least one defining factor associated with the 
telomere that enables the cell to recognize it as a separate entity from a double stranded 
break. 
Two related proteins, the TTAGGG repeat-binding factors TRF1 and TRF2, bind 
the lengths of mammalian telomeres (Chong et al. , 1995; Bilaud et al. , 1997; Broccoli et 
al. , 1997). Electron microscopic examination of telomeres has presented evidence 
suggesting that TRF2 induces a conformational change in the architecture of the 
telomeric ends, creating a t loop structure (Griffith et al. , 1999). Because a large TRF2 
protein complex was present at the loop-tail junction in all cases in Griffith's 
experiment, his data suggests that t loops are a product of the interaction between TRF2 
and the telomeric substrate. This t loop consists of a large duplex loop-back structure 
most likely formed through the invasion of the single-stranded telomeric 3' overhang 
into a section of the telomeric repeats located closer to the centromere. The presence of 
this lasso-like structure would solve the double stranded break problem presented by 
linear DNA. Because the linear end is buried within itself, there is no free end for the 
cell cycle checkpoints to detect. The inhibition of TRF2 immediately activates a DNA 
damage checkpoint pathway leading to cell cycle arrest (Karlseder et al. , 1999), further 
evidence that suggests that TRF2 and t loops are elements of the "sealing" process of the 
telomere. 
The mechanism through which telomeres are replicated was one of the first 
issues addressed by inquisitive researchers and is a problem that poses the most serious 
obstacle for telomere elongation research. Conventional DNA replication includes the 
priming of DNA by short RNA molecules, the extension of the new strand in the 5' to 3' 
direction, and the ligation of discontinuous pieces. This presents no problem at one end 
of each template strand, however, at the other end, there is an unreplicated segment 
when the primer is removed (Watson, 1972). Because of the involvement of this RNA 
primer, DNA polymerase ct cannot replicate the very end of a linear chromosome (Fig. 
2). In somatic cells, the absence of a telomere maintenance mechanism to overcome this 
"end-replication problem" results in the cells' failure to pass their complete genetic 
complement from generation to generation, or the degradation of the telomere each 
round of cell division. Approximately 50-200 base pairs (bp) of telomeric DNA are not 
replicated during each S phase. This constant telomeric dilapidation brings the cell 
closer to chromosomal instability each round of cell division, eventually leading to cell- 
cycle arrest and senescence, or cell death. 
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FIG. 2. The End Replication Problem (Blackburn and Greider, 1995) 
The removal of the primer after DNA replication results in a 3' overhang. 
Sertescence 
In 1881 the German biologist August Weismann speculated that somatic cells of 
higher animals would be found to have a limited doubling potential because "a worn-out 
tissue cannot forever renew itself, and because a capacity for increase by means of cell 
division is not everlasting but finite" (Weismann, 1891). Weismann's conjecture proved 
to be plausible when in 1961 the finite replicative capacity of normal human fibroblasts 
was described (Hayflick and Moorhead, 1961). It was shown that the death of cultured 
normal human cells was not due to some trivial cause involving medium components or 
culture conditions, but was an inherent property of the cells themselves (Hayflick, 1997). 
Senescence is cell death after a limited number of cell divisions. Cells that have 
undergone senescence are irreversibly arrested in the Gi phase of the cell cycle and are 
no longer sensitive to growth factor stimulation (Seshadri and Campisi, 1990). This 
genetically determined event is associated with several factors, one being the inability of 
the terminal sequences of telomeric DNA to replicate at each cell division. Although the 
exact mechanism of replicative senescence is unknown, several factors have been 
identified that affect this phenomenon, including free radicals present in the cell or its 
medium, telomere length, and the rate at which the telomere is degraded. 
In the past, researchers have supposed that the main cause behind the initiation of 
senescence was severely shortened telomere length. Although this appears to affect the 
rate at which the senescent phenotype appears, recent data supports that the telomere 
structure plays a significant role in this area as well. The sequence specific telomere 
binding protein TRF2 has shown to delay senescence by protecting critically short 
telomeres from fusion, which suggests that replicative senescence is induced by a change 
in the protected status of shortened telomeres rather than the complete loss of telomeric 
DNA (Karlseder et al. , 2002). Other research involving telomerase, a telomere specific 
polymerase, indicates that its introduction into the cell does not immediately result in net 
telomere lengthening, but rather that the telomeres continue to shorten for a period of 
time before a stable, short length is reached and cell life is extended (Zhu et al. , 1999; 
Yang et al. , 1999). This presents further evidence supporting that telomere maintenance, 
not exclusively telomere length, is critical for cell survival. A method to overcome the 
continual shortening of the telomere with every DNA replication may be necessary to 
achieve immortality in cells, however, cellular life extension could possibly be achieved 
through protection of the telomeric structure. 
The first evidence that human somatic cells might show terminal fragment loss, 
and therefore exhibit telomere degradation, was derived from observations that human 
telomeres are longer in sperm cells than in hemocytes (Cooke and Smith, 1986; Allshire 
et al. , 1998, 1999; Cross et al. , 1989; de Lange et al. , 1990; Hastie et al. , 1990). Human 
telomeres from somatic cells that have eroded from their maximum size of 10-15 kb (in 
the germ line) to an average size of 4-6 kb have shown to irreversibly arrest growth, 
producing a characteristic (senescent) phenotype (Campisi, 1997; Chiu and Harley, 
1997). Thus, the progressive shortening of the telomeres continues until the cell is 
unable to divide further (Bodnar et al. , 1998). 
Oxidative damage is another cellular stress that can cause premature cellular 
aging and growth arrest. Fibroblast cells cultured in conditions of mild hyperoxia 
showed a shortened replicative lifespan and exhibited an increased rate of telomere 
degradation (von Zglinicki et al. , 1995). Eukaryotic cells use strong oxidants housed in 
cytoplasmic organelles to destroy cellular waste products and subsequently remove them 
from the cell via exocytosis. Cells also use oxidizing agents to undergo cell-mediated 
apoptosis by the programmed release of these oxidants. In healthy cells, there will be 
some degree of oxidation or reactive oxygen species (ROS) present at any given time, 
however at a low concenu'ation. Specific culture conditions can significantly affect 
these oxidant levels, therefore having a direct affect on the rate in which cultured cells 
undergo replicative senescence. 
Several theories have identified senescence as functioning in part to eliminate or 
decrease the development of cancer (oncogenesis). The process of cell division innately 
puts the cells at risk for developing cancer as genomes are continually damaged by 
oxidative metabolism, the environment, and, in actual dividing cells, errors in DNA 
replication and mitosis. Maintenance and repair mechanisms are present in the cell, but 
this machinery is not always one hundred percent efficient. Dividing cells have the 
highest risk for genomic mutations, which are generated by failures or mistakes in repair. 
To protect against accumulation of these replicative errors, eukaryotic organisms 
undergo cellular senescence, an all-encompassing protection mechanism, to suppress the 
growth of cells at risk for oncogenic transformation. Cellular senescence is a major 
barrier that cells must overcome in order to progress to full-blown malignancy (Smith 
and Pereira-Smith, 1996; Campisi, 2000). This anti-oncogenic function is not without its 
adverse affects on the cell in vivo. Because senescent cells can, in theory, disrupt local 
tissue integrity, they might also contribute to age-related pathology (Campisi, 2001), 
The emerging idea is that when senescent cells accumulate, as they do later in life, they 
might actually facilitate tumorigenesis (Krtolica et al. , 2001). 
Genetic Modifications 
Different methods have been explored in attempts to delay the onset of 
senescence in vitro. This delay is of the utmost importance, as genetic modifications of 
eukaryotic cells in vitro require long periods of time in culture and multiple population 
doublings. The replicative potential of a cell is measured using units of population 
doublings (pds), or the number of times that a cell colony divides over a predetermined 
amount of time. Untreated somatic cells will become senescent after thirty to fifty pds, 
dependent on the cell type and the cell age upon initiation of the culture. On average, 
genetic modifications require about one hundred pds to complete. The discrepancy 
between the average pds of normal cells in vitro and the number of pds required for 
genetic modifications is one of the issues addressed by telomeric elongation research 
(»g 3) 
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FIG, 3. Standard Cell Growth Curve in vitro (Freshney, 2000) 
Telomeraxe 
The process of telomere degeneration can be overcome by the expression of 
hTERT, the catalytic subunit of the ribonucleotide complex of telomerase (Bodnar et al. , 
1998). Telomerase is a specialized DNA polymerase that has been shown to synthesize 
the terminal repeat sequences of chromosomes (TTAAGGG) and add them de novo to 
the G-rich 3' ends of the telomeres. In this way it counters the constant telomere 
degradation typical of the DNA polymerase ct mechanism. Thus, the telomeres of 
immortal cells do not continue to shorten with successive passage in vitro (Harley et al. , 
1990). 
This enzyme was first discovered in the ciliated protozoan Tetrahymena 
thermophila (Greider and Blackburn, 1985). Telomerase expression has been identified 
in four additional species, the human and the mouse being the only eukaryotes. In these 
eukaryotic organisms only specific cells express it, as it is active in germ cells and has 
moderate activity in stem cells (no normal expression is seen in somatic cells). Some 
somatic cells in vitro develop the expression of telomerase after an extended number of 
population doublings, but this expression is often the first stage of oncogenesis. 
Furthermore, telomerase activity has been detected in cancerous tumor cells in vivo. The 
level of telomerase activity found in normal cell populations, such as germ and stem 
cells, is significantly less per cell than that found in cancer cell populations (Wright et 
al. , 1996). It is possible that the high level of repression of telomerase in most somatic 
cells has been selected in long-lived species, such as humans, as a mechanism for 
reducing the frequency of cancer (Harley et al. , 1994). 
Normal levels of telomerase activity seem to have no adverse consequences to 
the cell. Research is currently being pursued concerning the initiation of telomerase 
activity in somatic cells in order to achieve fibroblast immortality in vitro. This involves 
the difficult process of inserting the hTERT subunit into a cell. Cells expressing hTERT 
have a normal karyotype and behave as normal cells do in response to cell-cycle 
inhibitors, serum deprivation, high cell density, and irradiation (Yang et al. , 1999; Jiang 
et al. , 1999; Morales et al. , 1999; Vaziri et al. , 1999). It is also indicated that only a very 
small average telomere elongation by hTERT resulted in a 50 10 increase in life span of 
human fibroblasts (Steinert et al. , 2000). These results suggest the potential safe use of 
hTERT in tissue engineering. 
Heterogeneous Nuclear Rtbonucleoprotein A 1 and UP1 
In recent years several proteins have been identified as having involvement with 
mammalian telomeres. These proteins all have different binding specificity; some 
associating exclusively with the telomeres, others with the protein complexes that are 
built at the chromosome end, and still others have a further affinity for additional cellular 
sites. While every one of the identified proteins' exact roles has not yet been identified, 
many of them appear to have some function in maintaining the length and/or structure of 
the telomere. 
The telomere's 3' overhang of the G-rich strand is subject to the most oxidative 
and replicative degradation. During DNA replication it is thought that the G-rich strand 
serves as the substrate for the synthesis of the complementary strand (Greider et al. , 
1989; Nugent and Lundblad, 1998). This is the process previously defined with its 
involvement of the RNA primer causing the incomplete replication of the lagging strand. 
Because the protein heterogeneous nuclear ribonucleoprotein (hnRNP) Al has been 
shown to associate with this area of the chromosome, it has received much attention. 
Moreover, hnRNP Al is capable of interacting with telomerase, which further suggests it 
performs an important role in telomere biology (LaBranche et al. , 1998). 
HnRNP Al is one of the most abundant core proteins of hnRNP complexes in 
eukaryotic nuclei. Along with its DNA annealing activity, the protein also shuttles 
continuously between the nucleus and the cytoplasm, a process managed by an export 
signal within its C-terminal glycine-rich domain (Pinol-Roma and Dreyfuss, 1992; 
Michael et al. , 1995). This shuttling suggests hnRNP Al may be involved in 
transporting mature mRNA to the cytosplasm (Xu et al. , 1997). It has been identified as 
having not only an association with the telomere, but also participating in telomere 
biogenesis (LaBranche, 1998) (Fig. 4). Increased expression of hnRNP Al and its 
shortened derivative UP1 promote telomere elongation in mammalian cells through 
direct interactions with the telomere (LaBranch, 1998). It is not clear whether hnRNP 
Al does this by protecting the telomere from shortening or by conserving the telomere's 
structure. 
3' 
FIG. 4. Proposed Manner in which UPI Binds Telomeric DNA (Ding et al. , 1999) 
Upi is represented by the bi-colored ovals, the light half rcprcscnting RRM1 and the dark half 
representing RRM2. 
The N-terminal region of hnRNP Al, designated unwinding protein I (UPI), 
preferentially binds to the G-rich telomeric overhangs at the 3' terminus (Dallaire et al. , 
2000). UPI runs the first 196 base pairs and functions exactly as hnRNP Al sans 
splicing ability (Mayeda et al. , 1994). This UPI fragment, or domain ofhnRNP Al, is 
composed of two stable, independently folded subdomains — subdomain I and 
subdomain II. Within subdomain I and subdomain II reside two highly conserved RNA- 
recognition motifs (RRMs), RRMI and RRM2, respectively (Xu et al. , 1997) (Fig. 5). 
The co-crystal structure of UP I suggests that both RNA binding domains can interact 
with telomeric DNA (Ding et al. , 1999), however it has been proposed that the two 
RRMs have distinct specificities: RRM I binds to telomeric DNA sequences while 
RRM2 simultaneously interacts with the RNA component of telomerase (Fiset and 
Chabot, 2001). These results are significant as the simultaneous interaction of Al/UPI 
with telomerase and telomeric DNA may help position telomerase for the extension of 3' 
overhangs (Fi set and Chabot, 2001). 
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FIG. 5. Structure of UP1 Bound to DNA (Ding et al. , 1999) 
Thc protein is represented by the ribbon structures and the bound DNA is represented by thc overlaid 
helices. 
HnRNP Al and its proteolytic fragment UP 1 have shown to play a direct role in 
telomere biogenesis (LaBranche, 1998). Both UP1 and hnRNP Al have proven to bind 
directly to telomeric DNA and it has subsequently been shown that the Al/UP1 binding 
to a long single-stranded oligonuceotide protects DNA from endonuclease and 
exonuclease attack (Dalliare et al. , 2000). The complete mechanism through which the 
telomere is protected is not clear, but there is evidence that the over-expression of 
Al/UP1 has some affect on cell life in culture (Dallaire et al. , 2000; LaBranche et al. , 
1998). Furthermore, recent data has additionally indicated that the binding of Al/UP1 to 
telomeric DNA may help shield the ends of chromosomes from nucleolytic attack and 
from surveillance mechanisms that detect double-stranded DNA breaks (Fiset and 
Chabot, 2001). 
MATERIALS AND METHODS 
Production of the Dominant-negative UPI 
Production of mRNA 
DNA was extracted from porcine fetal fibroblast cells grown in monolayer. The 
cells were lysed in the culture dish by trypsinization followed by the addition of I ml 
TRI REAGENT . RNA was then extracted by way of a kit from TRI REAGENT 
(Invitrogen, ¹15596026). 
The homogenate was stored at room temperature for five min followed by 
addition of 0. 2 ml chloroform. After the sample was shaken vigorously for 15 sec, the 
resulting mixture was stored at room temperature for ten min and subsequently 
centrifuged at 12, 000 g for 15 min at 4'C. Following centrifugation, the colorless upper 
aqueous phase containing the RNA (0. 6 ml) was removed and transferred to a fresh tube. 
The interphase and organic phase left in the original tube was discarded. 
The RNA was precipitated from the aqueous phase by the addition of 0. 5 ml 
isopropanol to the solution. The sample was then stored at room temperature for 5-10 
min followed by centrifugation at 12, 000 g for 8 min at 4'C. The supernatant was 
removed and the resulting pellet was washed by the addition of 1. 5 ml of 75'10 ethanol, 
vortexing, and centrifugation at 7, 500 g for 5 min at 4'C. The RNA pellet was then air- 
dried for ten min. At this point the RNA was solubilized in 15 td of nuclease-free water. 
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Reverse Transcri tion 
Reverse transcription was performed using the ProSTAR RT-PCR Kit 
(Stratagene, ¹200420). The control reaction was prepared by adding 2 /d of control 
mRNA to 36 pl of diethylpyrocarbonate (DEPC)-treated water. A separate experimental 
reaction of 10 Itg of fibroblast RNA and 28 pl of DEPC-treated water was also prepared. 
3 /tl of random primers (100 ng/pl) were added to both the control and experimental 
reactions and mixed gently. The samples were then incubated at 65'C for 5 min, 
followed by a cooling period at room temperature for ten min. The following 
components were then added to both reactions in the order listed: 
5 /tl of 10x first-strand buffer 
I /tl of Rnase Block Ribonuclease Inhibitor (40 U//tl) 
2 pl of 100 mM dNTPs 
I /d of StrataScript™ reverse transcriptase (50 U/pl) 
The control and the experimental reactions were mixed gently and subsequently 
incubated at 42'C for I hour. 
P~D 
Two primers were designed for the isolation of the UPI sequence. These 
primers, coined "pUP1" and "pUP2, " were designed to anneal to the DNA strand before 
and after the UP I sequence (amino acids 1-196). 
A porcine UPI sequence is currently not available. Therefore, DNA 
conservation between species was relied on to design the primers. A sequence 
comparison was made between human and mouse DNA (Fig. 6), and the sequences for 
the UP 1 primers were taken from a region conserved between the two species. 
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Additionally, the region seleceted incorporated three enzyme cut sites. The custom 
primers were then produced by Sigma-Genosys (Houston, TX). 
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FIG. 6. MacVector Human and Mouse Conservation Graph 
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Pol merase Chain Reaction 
The UPI RT-PCR products were pooled and 50 ttl of water was added to make a 
total volume of 300 Itl. The product was washed by adding an equal volume of phenol 
chloroform (300 itl) and centrifuging. The upper aqueous layer was extracted and 
transferred to a fresh tube. An equal amount of isopropanol was added to the sample and 
mixed gently, followed by a 5 min centrifugation. The supernatant was removed and the 
pellet was washed with 300 Itl of 70'/o ethanol. The UPI fragment was then dried for 3 
min in a spin-dry vacuum and immediately resuspended in 30 Itl of water. The DNA 
was sequenced through reverse transcriptase was sequenced with the custom Sigma- 
Genosys primers through a PCR reaction (94'C for 10 sec, 60'C for 30 sec, 68'C for 1 
min, 30 cycles). 
CR 2. 1-To o Vector 
Following the TOPO TA Cloning protocol, 4 Ids of the purified sequence 
product/water solution was mixed with 1 pl of salt solution and 1 pl Topo 2. 1 vector 
(Invitrogen, ¹K4500-40). The resulting solution was then incubated at room temperature 
for 5 min and 3 Itl were added to one vial of One Shot Top 10 E. coli cells. The 
mixture was then ready for transformation as described by the Promega protocol. The 
mix was incubated for 30 min on ice and afterward heat shocked for 30 sec at 42'C. 
Immediately following the heat shock, the cells were placed on ice for 2 min. The 
transformed cells were transferred into 200 Id of LB broth and placed at 37'C for one 
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hour with shaking at about 100 rpm. All 200 /tl were spread onto agar selection plates, 
which contained 60 /tl/ml X-Gal and 100 /tl/ml carbenicillin (Carb). The plates were 
incubated overnight at 37'C. The white colonies were picked and screened by 
restriction digestion with Fse I for the presence of the UP1 insert (Fse I site located on 
pUP I). 
The pShooter Expression Vector 
Isolation and Purification of the UPI Se uence 
The UPI fragment was cut out of the pCR 2. 1 Topo vector with the enzymes Not 
I and Nco 1(located on pUPI and pUP2). The fragment was then isolated and purified 
using QIAquick Gel Extraction Kit (Qiagen, //28704). The DNA was run on a I /0 
agarose gel and excised. 390 /tl of Buffer QG was added to the excised gel. The sample 
was incubated at 50'C for 10 min, with vortexing every 2 min during the incubation. 
The sample was then applied to a QIAquick spin column placed in a 2-ml collection 
tube, cennifuged for I min, and the flow-through discarded. 
To wash, 0. 75 ml of Buffer PE was added to the QIAquick column and 
centrifuged for I min, The flow-through was discarded and the column cenn1fuged for 
an additional min at 13, 000 rpm. The QIAquick column was then placed into a clean 
1. 5-ml microfuge tube and the DNA eluted by adding 30 ttl of water to the center of the 
QIAquick membrane, followed by cennifugation of the column for 1 min at maximum 
speed. 
24 
Clonin of UPI into Shooter Vector and Transformation 
The pShooter vector was cut by Nco I and Not I enzyme sites and purified by the 
same protocol as described for the UPI fragment. Upon pShooter purification, the 
purified UP I fragment was cloned into the vector. 100 ngs of the pShooter/UPI sample 
were added to one vial of One Shot E. coli competent cells and the mixture was 
incubated on ice for 30 min. Transformation was performed by the same protocol as 
described previously for the pCR 2. 1 Topo vector. Positive colonies were selected and 
DNA was harvested. 
O O» 
pc MV/myc/nuc 
5. 0 I&b 
FIG. 7. The pShooter Vector 
The Nco I and the Not I sites correspond to the sites on the UPI fragment. 
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Elect roporati on 
Di estion and DNA Pre aration for Electro oration 
70 tds of pShooter/UP1 DNA, 270 ttl water, 40 ttl buffer, and 20 pl Sca 1 enzyme 
(Roche Diagnostics, ¹775258) were combined and incubated at 37'C overnight. The 
resulting DNA was separated on a 1'/tt agarose gel to confirm the complete digestion. 
400 ttl phenol-chloroform isoamyl was added and the sample was shaken 
vigorously to achieve a homogenous mixture. The mixture was centrifuged at full speed 
for 5 min and the aqueous phase was extracted. An equal volume of isopropanol was 
added to the aqueous layer, the mixture shaken by hand, and left at room temperature for 
5 min. This was followed by centrifugation, again at full speed, for 5 min. The 
supernatant was removed and 500 td of 70'hatt ethanol added followed by 5 more min of 
centrifugation. The supernatant was poured out and the sample was centrifuged for 1 
min. The remaining liquid was aspirated with a pipette tip without disturbing the pellet. 
The pellet was vacuum dried for 5 min and resuspended in 50 pl endotoxin free TE 
buffer. The solution was set at 37'C for 30 min and centrifuged for 1 min at full speed. 
The concentration of the resulting DNA was checked using the spectrometer. 
~E1 t« tt 
Porcine fetal fibroblast cells were grown from frozen stock to a sub-confluency 
of 70-80'/E. The cells were then trypsinized and counted. Ten million cells were 
pelleted down and resuspended in 800 ttl of F10. 20 ttg of the pShooter/UP1 linearized 
DNA were added to the mix and the solution was left at room temperature for 10 min. 
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During the incubation, 30 ml of media (DMEM/F12 based, 10a o fetal bovine serum) 
were prepared in a 50 ml tube. The DNA-cell mixture was added to a 4mm cuvette and 
electroporated (450V, 4 pulses, I ms pulse length). The contents were then transferred 
to the prepared medium and mixed properly. The electroporated cells were added to 
fifteen plates at 2 ml/plate. 6 ml of additional media was added to each plate to make a 
volume of 8 ml of media per 100mm plate. 24 hours following the electroporation, the 
media was changed and neomycin, or G418, (Gibco, ¹1811) was added to the media at a 
predetermined concentration (ranging from 500 /tl/ml to 1, 100 /tl/ml dependent on plate 
surface area). In addition to the electroporated cells, a control set of 1. 5 million cells 
(from the same frozen stock) was seeded. These cells did not undergo electroporation 
and were not exposed to antibiotic. The remaining cells from the frozen stock were 
refrozen at -80'C for later assays. 
Population Doublings 
Colon Selection and Ex ansion 
Protocols for the isolation of cloned colonies followed those in Culture of Animal 
Cells; A Manual of Basic Technique protocol. Ten cloned colonies expressing G418 
resistance were marked, media removed, and the plate washed gently with PBS. With 
sterile forceps, a cloning ring was dipped in silicone grease and placed around each 
colony. 0. 4 ml of trypsin were added to each cloning ring, left on for 20 sec, and 
removed. The plates were then closed and incubated at 37'C for 15 min. 0. 4 ml of 
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medium was then added to each ring. Taking each colony in turn, the medium was 
pipetted up and down to disperse the cells, and transferred to one well of a 96-well plate. 
The ring was washed out with another 0. 4 ml of medium, and the media transferred to 
the same well with the cells. Cells were gradually expanded from 24 wells, to 6-well 
plates, and eventually to 100mm plates. 
Po ulation Doublin Factor 
Population doubling factor (PDF) was calculated as log (D/D, ), where D and D, 
are the density of cells at the time of harvesting and seeding, respectively. Sub- 
confluent (70-80'/0) plates were harvested by uypsinization once per week, cells 
counted, and PDF values calculated and plotted as a function of time. 
The cells were passed according to Culture of Animal Cells; A Manual of Basic 
Technique protocol. First the media was removed from each plate, followed by 5 ml of 
PBS wash with Magnesium. The PBS wash was removed and 2. 5 ml of trypsin added 
per 100 mm plate of cells, followed by immediate incubation for 4-6 min at 37'C. All 
cells were removed from the plate, counted, and centrifuged at 3, 000 rpm for 10 min. 
6x10 cells were resuspended in fresh media containing the determined amount of G418 
and plated at a density of 2x10 cells per 100mm plate. The cells unused for further 
population doublings were frozen in 0. 5-1. 0 of freezing media (40'/o fetal bovine serum, 
10'/0 DMSO, DMEM-F12 base), labeled according to their group, and kept at -80'C for 
later analysis. The population doublings were recorded for all sets of cells beginning 
day 1 as the day of electroporation and ending with day 98. 
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U~P1 E 
DNA samples of each of the five UP1 expressing colonies were extracted and 
mRNA was prepared through the protocol previously described. The mRNA was 
manipulated through reverse transcription and the resulting cDNA was analyzed through 
PCR reactions. 
Telomere Repeat Amplification Protocol 
Telomerase activity was measured using telomere repeat amplification protocol 
(TRAP) using a kit from Intergen (t)S7700). DNA was isolated from each of the 
samples and manipulated according to the TRAPeze kit instructions. 10 ng of protein 
extract were used per reaction and positive conn'ols were included with the gel. The 
tubes were first incubated for 30 min at 30'C and then a 2-step PCR (94'C for 30 sec, 
59'C for 30 sec at 30 cycles) was performed following the PCR reaction. The fragments 
were separated on a 6'IE denaturing polyacrylamide gel electorphorisis (600V, 45 min). 
The gel was scanned using an Alpha Innotech image acquisition and an analysis system 
then assessed the telomerase activity. Activity was calculated as a ratio of the intensity 
of the telomerase ladder to the intensity of the 36bp standard. 
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RESULTS AND DISCUSSION 
Production of the Dominant-negative UP 1 
Production of mRNA and cDNA 
The mRNA was successfully extracted and purified from porcine fetal fibroblast 
cells and cDNA was produced without difficulty. An adequate amount of cDNA was 
obtained through the original RT-PCR reaction so that further amplification was not 
necessary. 
~Pi D i ~ 
An important step in the research design was the creation of the UP1 primers. 
Because it was only necessary to amplify a segment of the DNA in order to achieve the 
over-expression of UP 1, two primers were designed and introduced into the PCR 
reaction. Three specific enzyme cut sites were incorporated into the primers (Fig. 8). 
By incorporating these sites, potential problems were eliminated in succeeding steps of 
the methodology. The Fse I enzyme (Promega) site created a system through which UP1 
expression could be verified in the transformed bacterial colonies. Likewise, the 
incorporation of Nco 1 and Not 1 (Promega) cut sites on pUP1 and pUP2, respectively, 
ensured that the UP1 fragment would orient correctly into the pShooter expression 
vector. The primer design created through the comparison of human and mouse DNA 
was adequate and the UP1 fragment was effectively isolated and amplified 
from the cDNA template. 
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pUPI: GGCCGG/CCATGGTGACGCCGCCGAAGAAGCATCG 
t Fse I and Nco I sites (respectively) 
pUP2: CCGGCCGCGGCCGCCCACTGCGACCTCTTTGGCTGGATGA 
t Not I site 
FIG. 8. Sequences of UPI Primers and the Incorporated Enzyme Sites. 
Pol merase Chain Reaction 
The PCR reaction combined the designed primers and the porcine cDNA. 
Production of the UP I fragment was confirmed through electrophoresis. The reaction 
was run on a 1% gel and a band between 500 and 600 bps was identified. 
CR 2. 1-To oVector 
The plasmid vector Topo 2. 1 was chosen for several reasons. Its replication is 
unidirectional, it has a smaller size that allows it to transform at higher frequencies than 
a larger plasmid, and it is encoded with selective antibiotic resistance. To confirm the 
successful ligation of the UPl segment into the 2. 1-Topo vector, the DNA extracted 
from the selected positive colonies was cut with Fse I enzyme (Promega). The samples 
were run as uncut and cut, side by side on the same gel in order to facilitate a simple 
comparison (Fig. 9). From these results, three colonies were selected for transformation, 
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iw fje 
~ 0% e. ear 
I Jncut Cut 
FIG. 9. Topo 2. 1/DNA Samples Run On a Gel. 
The two samples indicated with arrows are positive for the vector and Upi insert. 
The transformation of the DNA into E. coli cells resulted in numerous white 
colonies (white colonies are indicative of a positive transformation due to the X-gal 
supplemented agar plates). There was no visible contamination and the transformed 
colonies grew quickly. 
The pShooter Expression Vector 
Isolation and Purification of the UPI Se uence 
Pshooter (pCMV/myc/nuc) is a nuclear localization vector that signals the 
transformed cells to shuttle the protein being expressed (UPI) to the cells' nuclei. In 
addition, the pShooter vector encodes for neomycin (G418) and ampicillin antibiotic 
resistance. The UPI fragment was successfully excised from the 2. 1-Topo vector and 
purified with the Qiagen Gel Extraction Kit (Qiagen, ¹28704). 
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Clonin of UPI into Shooter Vector 
The UP1 primer design ensured the correct orientation of the UP1 fragment into 
the pShooter vector. Because the two separate enzyme sites (located on opposite ends of 
the UP1 sequence) only match in one direction with the pShooter sites, the possibility of 
incorrect orientation was eliminated. UP1 was cloned effectively into the pShooter 
expression vector and transformed into competent E. coli cells following the Promega 
protocol for transformation. The transformation resulted in multiple positive bacterial 
colonies. 
Electroporati on 
Di estion and DNA Pre aration for Electro oration 
The p Shooter/UP1 DNA was harvested from the positive colonies and purified. 
Portions of the samples were then run through the spectrometer and their concentration 
was recorded (3. 3 /tg/ml, 1. 79 /zsii). The results indicated the amount of DNA needed 
for the electroporation. 
The DNA was then linearized by the Sca I enzyme. There is one Sca I cut site 
located on the pShooter vector at base 4535. The digested DNA was run on a 1'/o 
agarose gel. A band at 5. 5 kb was located that confirmed the sample consisted of the 
pShooter vector and the UP1 fragment and was in fact linear (data not shown). The 
linearization of DNA prior to electroporation is important as it increases the efficiency of 
the transformation. 
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Electro oration and Colon Selection 
Upon linearization of the DNA, the cells were electroporated into 10 million 
porcine fetal fibroblast cells and plated at about 6. 7x10 cells per plate. Prior to 
electroporation, wild-type cells were grown in culture and exposed to different 
concentrations of G418 in order to achieve the ideal antibiotic concentration for 
selection of the electroporated cells (kill curve). The cells were plated at a density of 
1. 0x10 cells per well of a 6-well plate and observed over fourteen days. Additional 
cells were plated in 100mm plates at the concentrations of 1, 000 /ig/ml and 1, 100 /tg/ml 
and observed for the same amount of time. The concentrations 700 /tg/ml was identified 
as the ideal for a 6-well plate, and 1, 000 /ig/ml was identified for a 100mm plate. The 
electroporated cells were then subjected to these concentrations. 
From the ten colonies originally marked, seven were moved to a 24-well plate after 
two days by the protocol described in the methodology section. From these seven 
colonies, five were transferred to a 6-well plate after an additional five days. All five of 
these colonies were selected for the population doubling experiment and were eventually 
expanded to three 100mm plates each. 
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Populaiion Doubli ngc 
Po ulation Doublin Factor 
Over a 300'ro increase in population doubling potential was seen in the porcine fetal 
fibroblast cells electroporated with the UPI insert (Fig, 10). The control cells reached 
senescence around thirty pds, a characteristic distinctive of the wild-type somatic cell 
life span. In contrast, the sample groups eletItroporated with the UPI insert achieved a 
higher number of pds in the same amount of time and generally did not express a 
decreased rate of division. Therefore, these results indicate cellular life extension of 
somatic cells expressing UP1 in vitro. 
A comparison of the growth rates amongst the cell groups reaffirmed a significant 
difference in life span between the control and UP 1 cells. Illustrated by the graphical 
data (Fig. 10), the growth rates between the control cells and the UP I-expressing cells 
match closely days 4 — 48 (indicated by comparison of the slopes of the separate lines). 
Around day forty-eight the control cells begin to display signs corresponding to the 
senescent phenotype as they diverged from the initial growth rate (forty-eight days is 
equivalent to 25 pds). From day 48 on, the data plot representing the control's growth 
curve begins to level out as the rate of growth decreases. This is indicated by the control 
graph exhibiting a diminishing slope after day 48. 
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FIG. 10. PDF Data 
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In contrast to the control set, UP1-expressing cells exhibit a stabilized growth rate, 
characteristic of the initial 48 days in culture, until the PDF experiment was ceased. 
Between the UP I samples themselves there was some variability present as groups ¹10 
and ¹11 appear to approach senescence more rapidly than the others. While ¹10 and ¹11 
did move toward a senescent phenotype, it is important to note that at the time their 
growth rate slows, the colonies are well above the standard number of pds typical of 
wild-type somatic cells in vitro. The variation observed between the UP1 over- 
expressing cells could be due to the location of the UP1 insert in the porcine cells' DNA. 
This positional effect could be caused by several different factors including the number 
and location of promoters in the DNA. 
U~Pl E 
DNA samples of each of the five UPI expressing colonies were extracted and 
mRNA was prepared. The mRNA was manipulated through reverse transcription and 
the resulting cDNA was analyzed through PCR reactions. The data produced from these 
reactions concluded that UP I was being expressed to a higher level in the cloned cells 
(Fig. 11). 
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FIG. 11. UP1 Expression 
Higher expression is seen in samples 7-11 as compared to the control itabeled C). 
Telomere Repeat Amplification Protocol 
No telomerase activity was found in the control cells or the UP1 expressing cells 
(Fig. 12). The implications from this data confirm that the extended cell life shown in 
the UP1 cells is not the result of telomerase activity, and therefore attributable to some 
other factor. 
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FIG. 12. Telomerase Expression 
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CONCLUSIONS 
It has previously been shown that the heterogeneous nuclear ribonucleoprotein 
Al participates in telomere biogenesis (LaBranche et al. , 1998). Furthermore, it has 
been indicated that UP1, the dominant-negative domain ofhnRNP Al, binds to 
telomeric DNA and provides protection against the activity of endo- and exonucleases 
(Dallaire et al. , 2000). This research project investigates the effects of UPI, the 
dominant-negative derivative ofhnRNP Al, on porcine fetal fibroblasts in vitro. 
The cells expressing the UP1 derivative exhibited a definite increase in cellular 
lifespan. However, without further testing, it cannot be definitively concluded that UP1 
over-expression is responsible for this abnormal phenotype. A karyotyping assay is 
necessary to examine the chromosome stability and identify if the extended growth is 
due to abnormalities within the chromosome as opposed to an affect of the UPI 
expression. Karyotyping results indicating normal chromosomes would suggest UP1 
had some affect on the extended life of the porcine cells in culture. 
If normal karyotyping results did occur, telomere restriction fragment analysis 
could be conducted. This assay would measure the length of telomeres throughout the 
stages of the experiment using the cells frozen at each passage. The results from this 
experiment could provide information involving whether the elongation of the telomere 
or the maintenance of telomeric structure is more important in the extension of cellular 
li fespan. 
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The results from the PDF trials did indicate cellular life extension in somatic 
cells expressing UP1. Further tests examining cellular karyotype and telomere tenth 
must be explored before any definitive conclusions can be drawn; however, the PDF 
experimental data yielded encouraging results as to the prospect of somatic cellular life 
extension in vitro. 
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